Tissue peptides
ARA-290
- 5 mg
- 10 mg
Custom strengths on request
Not FDA-approved. On FDA's 503A list (May 14, 2026): Category 3, nominated without adequate support. Source, May 14, 2026
At a glance
These dosages are a helpful guide, not a prescription. Every clinician is expected to do their own due diligence before prescribing.
Start
4 mg subcutaneous daily
Human study
- Frequency
- daily
- Route
- subcutaneous (self-administered)
- Course
- 28 days
Trial doses are route-specific: 2 mg IV three times weekly does not convert to 4 mg SC daily, and 8 mg/day showed no added benefit.
Get a quote
Custom strengths on request. Prices are quoted per clinic.